One-year single-center follow-up study of ustekinumab and vedolizumab use in inflammatory bowel disease Egyptian patients as second-line therapy after anti-TNF failure - Kamel, Shimaa; Alaty, Waleed Hamed Abd; Rashad, Heba; Fathy, Dina; Abdel-Samiee, Mohamed; Hindy, Ibrahim; Shaban, Ahmed; Askar, Safaa (Gastroenterology Review/Przegląd Gastroenterologiczny, 2025)